ARS Share Price
NASDAQ: SPRY | Micro Cap | HealthcareARS Stock Performance
ARS Share Price Today
As of 22 November 2026, ARS Pharmaceuticals, Inc.'s share price is $2.96. The stock opened at $3.40, compared to its previous close of $3.38. During today's trading session, ARS Pharmaceuticals, Inc.'s share price traded between $2.86 and $3.46, with an average price of $3.16. Over the past 52 weeks, the stock has recorded a high of $13.14 and a low of $2.46. In terms of performance, ARS Pharmaceuticals, Inc.'s share price has declined by 67.36% over the last six months and is down 68.94% on a year-on-year basis.
ARS Share Price Chart
ARS Quarterly Profit & Loss
All figures in USD
ARS Annual Profit & Loss
All figures in USD
ARS Balance Sheet
All figures in USD Million
ARS Cash Flow
All figures in USD Million
About ARS
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
ARS Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $3.48 | $2.96 | -12.44% |
Oct 2026 | $4.36 | $3.38 | -22.06% |
Sep 2026 | $5.99 | $4.33 | -28.07% |
Aug 2026 | $5.02 | $6.02 | +17.81% |
Jul 2026 | $8.01 | $5.11 | -36.20% |
Jun 2026 | $9.25 | $8.01 | -11.69% |
May 2026 | $8.28 | $9.07 | +9.94% |
Apr 2026 | $8.18 | $8.25 | +2.75% |
Mar 2026 | $8.99 | $8.03 | -13.67% |
Feb 2026 | $10.00 | $9.30 | -7.09% |
Jan 2026 | $11.52 | $10.01 | -14.15% |
Dec 2025 | $9.37 | $11.66 | +22.35% |